ArticleCancers2026

The Prognostic Value of Proclarix in Prostate Cancer Patients Under Active Surveillance: Predicting Transition to Active Treatment and Disease Progression in a Danish Cohort.

Alcibiade Athanasiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.